> >
All Biotech/pharma Articles

By Josh Wolonick May 20, 2013 11:20 am

Plus, there were purchases at Lionbridge Technologies and LivePerson.  Read this article

The Angelina Jolie Connection: The Debate Over Patenting Human Genes
Josh Wolonick
In Danish Laboratories, Hope Looms Large for a Permanent HIV Cure
Valorie Sands
Legendary Investors Bet Big on Boomer Biotechs
Valorie Sands
Pfizer's Disappointing Performance Could Increase Pressure to Split the Company
Quartz
With Mental Health Emergency Care, Insurers Bank on Hassle Factor
Alex Brokaw
Aragon Pharma's ARN-509 Is No Near-Term Threat to Medivation
David Miller
Best Stocks: Biotech Still Holding Top Spots
StateOfTheMarkets.com
Best Stocks: Four New Names, Four New Buys
StateOfTheMarkets.com
Biotechs That Tackle Toxicity: Huge Global Market Awaits
Valorie Sands
Chart of the Day: Expect UnitedHealth Stock to Hit All-Time Highs
RiskReversal.com
David & Goliath: Small Biotechs Wage a Big Fight Against the Superbug
Valorie Sands
Insider Trading: Two Insiders Sell Facebook Stock, Three Buys at Tetraphase Pharmaceuticals
Josh Wolonick
Drug Rejection Draws Out Pfizer Bears
Schaeffer's Investment Research
Best Stocks: All Biotech All the Time
StateOfTheMarkets.com
Top Insider Trades: Liberty Media Increases Stake in Live Nation, and Three Major Buys at Allscripts
Jonathan Moreland
Strange Business: Medical Marijuana Vending Machines Make a Comeback in San Diego
Christopher Witrak
The Case of Myriad Genetics: Should Companies Own Patents on Human Genes?
Josh Wolonick
Option Traders See Gilead Sciences Running Out of Steam
Schaeffer's Investment Research
Celgene Corporation Bulls Predict New Near-Term Highs
Schaeffer's Investment Research
Chart of the Day: Amgen Hits All-Time High
RiskReversal.com
Are Global Health Care ETFs Worth Prescribing?
Benzinga.com
After Stock Plunges, Maybe Affymax News Isn't So Bad?
Brett Chase
Pharmacyclics, Johnson & Johnson Nab Breakthrough Designation for New Cancer Drug
Brett Chase
Regeneron Shares Jump as Sanofi Increases Stake
Brett Chase
Why It's Risky to Be Short the Dollar or Long the Euro
Trading On The Mark
Six Things to Watch at Biotech CEO Conference
Brett Chase
Celgene Gets OK to Sell Blood Cancer Drug
Brett Chase
Biogen Idec Shares Rise on Deal for Elan's Share of MS Drug
Brett Chase
Hemispherx's Chronic Fatigue Drug Rejected by FDA
Brett Chase
Four Closely Watched Drug Decisions Loom in February
Brett Chase

Recommendations

TICKERS

PFE
MRK
BMY
JNJ
GSK
DNDN
VRTX
LLY
GILD
AMGN
ARNA
BIIB

Financial Product Guide